Home › Funds › BAUPOST GROUP LLC/MA › ELV

BAUPOST GROUP LLC/MA position in ELV

ELEVANCE HEALTH INC FORMERLY · Health Care

BAUPOST GROUP LLC/MA reported holding 1,275,154 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q1 2026 13F filing — a position valued at US$373.3M, representing 7.30% of its reported portfolio and ranking #5 among its reported holdings. BAUPOST GROUP LLC/MA has disclosed ELV holdings in 5 of the last 5 reported quarters, going back to Q1 2025.

Latest position (Q1 2026)1.28M sh
Reported value held$373.30M
Portfolio Weight7.30%
First reportedQ1 2025
Last changeHold
Updated2026-10-23

Last updated: 2026-10-23 · Source: SEC EDGAR Form 13F-HR

How BAUPOST GROUP LLC/MA's ELV position evolved

BAUPOST GROUP LLC/MA first disclosed a stake in ELV in Q1 2025 at 246,000 shares (US$107.0M). The position peaked in Q4 2025 at 1,269,302 shares, worth US$445.0M. Across 5 filings, BAUPOST GROUP LLC/MA increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q1 2026) shows 1,275,154 shares valued at US$373.3M. Notable position changes include a 150% increase in Q2 2025 (shares fell 16% over the following quarter), a 114% increase in Q3 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 246.00K $107.00M New
Q2 2025 616.00K $239.60M Add
Q3 2025 1.32M $426.19M Add
Q4 2025 1.27M $444.95M Reduce
Q1 2026 1.28M $373.30M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELV and 13F data

ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.25B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELV

All ELV fund holders →

FAQ

How long has BAUPOST GROUP LLC/MA held ELV?

BAUPOST GROUP LLC/MA has disclosed ELV holdings in 5 of the last 5 reported quarters, going back to Q1 2025.

What is BAUPOST GROUP LLC/MA's current position in ELV?

As of Q1 2026, BAUPOST GROUP LLC/MA holds 1.28M shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $373.30M, representing 7.30% of its reported portfolio and ranking #5.

Has BAUPOST GROUP LLC/MA been buying or selling ELV?

In the latest 13F filing (Q1 2026), BAUPOST GROUP LLC/MA held unchanged its position in ELV. The position peaked in Q4 2025 at 1.27M shares.

Which other funds hold ELV?

Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.